Head-to-head · Value Score
CoreAge Rx vs Navio MD
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Navio MD a 75. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameNavio MD
#133 · Grade C+ · Fair Price
Est. first month
From $189/mo (starting dose, compounded)
Save ~86% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 75 — an est. $149/mo first month, with no teaser step-up baked in. Navio MD isn't out of it: Shoppers who want compounded tirzepatide with brand-name fallback across 48 states.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Navio MD |
|---|---|---|
| Value Score | 93 (A+) | 75 (C+) |
| Est. first month | $149/mo | From $189/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~86% |
| Semaglutide | $149/mo | From $345/mo (starting dose, brand-name) |
| Tirzepatide | $349/mo | From $189/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 48 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Navio MD
NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).
Why it's a deal
- LegitScript verified with board-certified providers and US-licensed pharmacies
- Both compounded and brand-name options
- 48-state coverage
- Hours 9am–10pm EST Mon–Sun
- Transparent tiered pricing: you only pay for your current dose
The fine print
- Not available in Alabama and Mississippi
- Compounded option is tirzepatide only — no compounded semaglutide listed
- Also offers women's HRT (broader platform)
- Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to Navio MD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.